Percutaneous intratumoral injection of gemcitabine plus cisplatin mixed with fibrin glue for advanced pancreatic carcinoma
Open Access
- 1 September 2017
- journal article
- case report
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (37) , e8018
Abstract
The aim of this study was to determine the effectiveness of intratumoral injection of chemotherapeutics in improving the quality of life and survival of patients with pancreatic carcinoma. We present a case series of 5 patients with unresectable pancreatic adenocarcinoma. Patients diagnosed with unresectable poorly differentiated pancreatic ductal adenocarcinoma by intraoperative frozen biopsyor percutaneous biopsy. Five patients with unresectable pancreatic adenocarcinoma received a computed tomography-guided percutaneous intratumoral injection of gemcitabine plus cisplatin mixed with fibrin glue. Mean overall survival was 16.2 ± 3.7 months. Local control rates were 100% and 80% at postoperative 3 and 6 months, respectively. Mean Visual Analogue Scale pain score decreased from 7.2 ± .84 preoperatively to 2 ± 1.22 at postoperative 4 weeks. There were no complications associated with the procedure. Percutaneous intratumoral injection of gemcitabine plus cisplatin mixed with fibrin glue for advanced pancreatic may be safe and effective.Keywords
This publication has 19 references indexed in Scilit:
- Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas CarcinomaIntegrative Cancer Therapies, 2013
- Efficacy of minimally invasive therapies on unresectable pancreatic cancerChinese Journal of Cancer, 2013
- Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancerCancer Gene Therapy, 2012
- Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010World Journal of Gastroenterology, 2011
- Intraoperative radiofrequency ablation combined with125iodine seed implantation for unresectable pancreatic cancerWorld Journal of Gastroenterology, 2010
- A Phase I Trial of Arterial Infusion Chemotherapy with Gemcitabine and 5-Fluorouracil for Unresectable Advanced Pancreatic Cancer after Vascular Supply Distribution via Superselective EmbolizationJapanese Journal of Clinical Oncology, 2008
- Local EUS–guided injection of chemotherapeutic agents as adjuvant to systemic treatment: the first steps are madeGastrointestinal Endoscopy, 2007
- Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse modelSurgery, 2006
- Evaluation of the Efficacy of Combined Continuous Arterial Infusion and Systemic Chemotherapy for the Treatment of Advanced Pancreatic CarcinomaCardioVascular and Interventional Radiology, 2006
- Development of a local antibiotic delivery system using fibrin glueJournal of Controlled Release, 1996